Lambris JD - Search Results

1

Complement C3 inhibition in severe COVID-19 using compstatin AMY-101.

Skendros P, Germanidis G, Mastellos DC, Antoniadou C, Gavriilidis E, Kalopitas G, Samakidou A, Liontos A, Chrysanthopoulou A, Ntinopoulou M, Kogias D, Karanika I, Smyrlis A, Cepaityte D, Fotiadou I, Zioga N, Mitroulis I, Gatselis NK, Papagoras C, Metallidis S, Milionis H, Dalekos GN, Willems L, Persson B, Manivel VA, Nilsson B, Connolly ES, Iacobelli S, Papadopoulos V, Calado RT, Huber-Lang M, Risitano AM, Yancopoulou D, Ritis K, Lambris JD. Skendros P, et al. Among authors: lambris jd. Sci Adv. 2022 Aug 19;8(33):eabo2341. doi: 10.1126/sciadv.abo2341. Epub 2022 Aug 17. Sci Adv. 2022. PMID: 35977025 Free PMC article.

2

Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression.

Nilsson B, Grossberger D, Nilsson Ekdahl K, Riegert P, Becherer DJ, Nilsson UR, Lambris JD. Nilsson B, et al. Among authors: lambris jd. Biochem J. 1992 Mar 15;282 ( Pt 3)(Pt 3):715-21. doi: 10.1042/bj2820715. Biochem J. 1992. PMID: 1372802 Free PMC article.

3

Structural and functional analysis of C3 using monoclonal antibodies.

Alsenz J, Becherer JD, Nilsson B, Lambris JD. Alsenz J, et al. Among authors: lambris jd. Curr Top Microbiol Immunol. 1990;153:235-48. doi: 10.1007/978-3-642-74977-3_13. Curr Top Microbiol Immunol. 1990. PMID: 1688755 Review. No abstract available.

4

Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides.

Nilsson B, Nilsson Ekdahl K, Avila D, Nilsson UR, Lambris JD. Nilsson B, et al. Among authors: lambris jd. Biochem J. 1990 May 15;268(1):55-61. doi: 10.1042/bj2680055. Biochem J. 1990. PMID: 1693076 Free PMC article.

5

Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation.

Nilsson B, Larsson R, Hong J, Elgue G, Ekdahl KN, Sahu A, Lambris JD. Nilsson B, et al. Among authors: lambris jd. Blood. 1998 Sep 1;92(5):1661-7. Blood. 1998. PMID: 9716594 Free article.

6

In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC.

Lubinski J, Wang L, Mastellos D, Sahu A, Lambris JD, Friedman HM. Lubinski J, et al. Among authors: lambris jd. J Exp Med. 1999 Dec 6;190(11):1637-46. doi: 10.1084/jem.190.11.1637. J Exp Med. 1999. PMID: 10587354 Free PMC article.

7

Phylogenetic aspects of the complement system.

Zarkadis IK, Mastellos D, Lambris JD. Zarkadis IK, et al. Among authors: lambris jd. Dev Comp Immunol. 2001 Oct-Dec;25(8-9):745-62. doi: 10.1016/s0145-305x(01)00034-9. Dev Comp Immunol. 2001. PMID: 11602194 Review.

8

Herpes simplex virus type 1 evades the effects of antibody and complement in vivo.

Lubinski JM, Jiang M, Hook L, Chang Y, Sarver C, Mastellos D, Lambris JD, Cohen GH, Eisenberg RJ, Friedman HM. Lubinski JM, et al. Among authors: lambris jd. J Virol. 2002 Sep;76(18):9232-41. doi: 10.1128/jvi.76.18.9232-9241.2002. J Virol. 2002. PMID: 12186907 Free PMC article.

9

Complement: more than a 'guard' against invading pathogens?

Mastellos D, Lambris JD. Mastellos D, et al. Among authors: lambris jd. Trends Immunol. 2002 Oct;23(10):485-91. doi: 10.1016/s1471-4906(02)02287-1. Trends Immunol. 2002. PMID: 12297420 Review.

10

Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.

Molina H, Miwa T, Zhou L, Hilliard B, Mastellos D, Maldonado MA, Lambris JD, Song WC. Molina H, et al. Among authors: lambris jd. Blood. 2002 Dec 15;100(13):4544-9. doi: 10.1182/blood-2002-06-1875. Epub 2002 Aug 1. Blood. 2002. PMID: 12393518 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

519 results

Search Page